View in EDS HTML Full Text PDF Full Text

Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii.

Saved in:
Bibliographic Details
Title: Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii.
Authors: Baker S; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.; IAVI, Chelsea and Westminster Hospital, London, UK., Krishna A; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Higham S; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK., Naydenova P; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., O'Leary S; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Scott JB; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Harcourt K; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., Forrest S; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., Goulding D; Pathogens and Microbes Programme, Wellcome Sanger Institute, Cambridge, UK., Thi Nguyen TN; Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Toan ND; Neonatal Intensive Care Unit, Children's Hospital 1, Ho Chi Minh City, Vietnam., Alekseeva E; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Zhou Q; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Andreozzi I; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Sobotic B; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Craig H; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Wong V; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Forrest-Owen N; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Sanchez DM; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Pearce C; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Roberts L; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK., Watson S; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK., Clare S; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., Torok ME; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., Dougan G; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK., Kellam P; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK., Tregoning JS; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK., Reece ST; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK. stephen.reece@sanofi.com.
Source: Nature communications [Nat Commun] 2024 Sep 12; Vol. 15 (1), pp. 7979. Date of Electronic Publication: 2024 Sep 12.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39266557
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baker+S%22">Baker S</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.; IAVI, Chelsea and Westminster Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Krishna+A%22">Krishna A</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Higham+S%22">Higham S</searchLink>; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK.<br /><searchLink fieldCode="AU" term="%22Naydenova+P%22">Naydenova P</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Leary+S%22">O'Leary S</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Scott+JB%22">Scott JB</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Harcourt+K%22">Harcourt K</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Forrest+S%22">Forrest S</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Goulding+D%22">Goulding D</searchLink>; Pathogens and Microbes Programme, Wellcome Sanger Institute, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Thi+Nguyen+TN%22">Thi Nguyen TN</searchLink>; Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Toan+ND%22">Toan ND</searchLink>; Neonatal Intensive Care Unit, Children's Hospital 1, Ho Chi Minh City, Vietnam.<br /><searchLink fieldCode="AU" term="%22Alekseeva+E%22">Alekseeva E</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Zhou+Q%22">Zhou Q</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Andreozzi+I%22">Andreozzi I</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sobotic+B%22">Sobotic B</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Craig+H%22">Craig H</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wong+V%22">Wong V</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Forrest-Owen+N%22">Forrest-Owen N</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sanchez+DM%22">Sanchez DM</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Pearce+C%22">Pearce C</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Roberts+L%22">Roberts L</searchLink>; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.<br /><searchLink fieldCode="AU" term="%22Watson+S%22">Watson S</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Clare+S%22">Clare S</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Torok+ME%22">Torok ME</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dougan+G%22">Dougan G</searchLink>; University of Cambridge School of Clinical Medicine Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kellam+P%22">Kellam P</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK.; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK.<br /><searchLink fieldCode="AU" term="%22Tregoning+JS%22">Tregoning JS</searchLink>; Department of Infectious Disease, Imperial College London, St Marys Campus, Norfolk Place, London, UK.<br /><searchLink fieldCode="AU" term="%22Reece+ST%22">Reece ST</searchLink>; Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, UK. stephen.reece@sanofi.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Sep 12; Vol. 15 (1), pp. 7979. <i>Date of Electronic Publication: </i>2024 Sep 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39266557
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-52357-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7979
    Titles:
      – TitleFull: Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baker S
      – PersonEntity:
          Name:
            NameFull: Krishna A
      – PersonEntity:
          Name:
            NameFull: Higham S
      – PersonEntity:
          Name:
            NameFull: Naydenova P
      – PersonEntity:
          Name:
            NameFull: O'Leary S
      – PersonEntity:
          Name:
            NameFull: Scott JB
      – PersonEntity:
          Name:
            NameFull: Harcourt K
      – PersonEntity:
          Name:
            NameFull: Forrest S
      – PersonEntity:
          Name:
            NameFull: Goulding D
      – PersonEntity:
          Name:
            NameFull: Thi Nguyen TN
      – PersonEntity:
          Name:
            NameFull: Toan ND
      – PersonEntity:
          Name:
            NameFull: Alekseeva E
      – PersonEntity:
          Name:
            NameFull: Zhou Q
      – PersonEntity:
          Name:
            NameFull: Andreozzi I
      – PersonEntity:
          Name:
            NameFull: Sobotic B
      – PersonEntity:
          Name:
            NameFull: Craig H
      – PersonEntity:
          Name:
            NameFull: Wong V
      – PersonEntity:
          Name:
            NameFull: Forrest-Owen N
      – PersonEntity:
          Name:
            NameFull: Sanchez DM
      – PersonEntity:
          Name:
            NameFull: Pearce C
      – PersonEntity:
          Name:
            NameFull: Roberts L
      – PersonEntity:
          Name:
            NameFull: Watson S
      – PersonEntity:
          Name:
            NameFull: Clare S
      – PersonEntity:
          Name:
            NameFull: Torok ME
      – PersonEntity:
          Name:
            NameFull: Dougan G
      – PersonEntity:
          Name:
            NameFull: Kellam P
      – PersonEntity:
          Name:
            NameFull: Tregoning JS
      – PersonEntity:
          Name:
            NameFull: Reece ST
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 09
              Text: 2024 Sep 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1